Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2024QJM

Efficacy of Aphrodisiac Drugs Combination with Phosphodiesterase-5 (PDE5) Inhibitors in Patients with Erectile Dysfunction (Pilot Study)

View Full Paper
Ask AI
Bookmark
Share

Authors

TZTarek ZaherAin Shams UniversityATAhmed Mohamed TawfeekAin Shams UniversityMAMohammed Ayman Sayed Ahmed

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Zaher et al. (2024) studied this question.

synapsesocial.com/papers/68e673f0b6db6435875fe4abhttps://doi.org/10.1093/qjmed/hcae070.634
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1(187) Efficiency and Safety of Combining Long-Acting and Short-Acting PDE5 Inhibitors2024
  2. 2Oral drug treatments of erectile dysfunction: a AFU/SFMS systematic review2025 · 1 citations
  3. 3(782) Combined Use of Tadalafil and Vardenafil in Men with Erectile Dysfunction Non-Responsive to Monotherapy With a Single PDE5 Inhibitor: Clinical Rationale and Preliminary Outcomes2026
  4. 4(245) Efficacy and Tolerability of a Novel Formulation Using a Sildenafil Oral Suspension in Patients with Moderate-To-Severe Erectile Dysfunction2026
  5. 5Icarifil in Association with Daily Use of Tadalafil (5 mg) versus Standard Tadalafil Daily Dose (5 mg) or Alone: Results from a Controlled, Randomized Clinical Trial2024 · 1 citations